Clinical Trial

Effectiveness of Two Icodextrin Exchanges on Fluid Status and Blood Pressure Control Compared to a Single Icodextrin Exchange

Not Yet Recruiting
View on ClinicalTrials.gov →
Summary
Fluid overload and hypertension are prevalent in children undergoing chronic peritoneal dialysis (PD), especially in low- and middle-income countries (LMICs). These complications often lead to increased hospitalizations, higher medication use, and, in some cases, conversion to hemodialysis. Icodextrin is used to enhance ultrafiltration (UF) and reduce glucose exposure, but its effectiveness in children with a single long dwell has been inconsistent. Preliminary observations suggest that shorter, twice-daily icodextrin exchanges may improve UF and blood pressure (BP) control. However, no randomized trial has evaluated this approach in pediatric patients.
Protocol Amendment History 2 amendments
This ClinicalTrials.gov record has been amended 2 times since 2025-09-04; most recent amendment 2026-01-18.
Trial Details
NCT Number NCT07168343
Lead Sponsor National University Health System, Singapore
Collaborators: The UCL Great Ormond Street Institute of Child Health, Children's Hospital of Fudan University, Philippine Children's Medical Center
Conditions Children on Chronic Peritoneal Dialysis
Enrollment 10 participants
Start Date 2026-02-28
Primary Completion 2028-06-30 (estimated)
Study Completion 2028-06-30 (estimated)
Updated on ClinicalTrials.gov 2026-01-21